Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Noviral International AB
AB
Active
Org 5590683651
Humlegårdsgatan 4, 114 46
Stockholm
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 2016
0 employees
Watchlist
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Noviral International AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
4M
9M
13M
17M
15M
2020
10M
2021
0M
2022
0M
2023
0M
2024
EBITDA
SEK millions
0M
1M
2M
3M
3M
3M
2020
2M
2021
0M
2022
0M
2023
0M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
14 964
10 367
47
−0
−0
Staff expenses
—
—
−0
−0
−0
EBITDA
3 122
2 127
−12
−4
3
Depreciation & amort.
−0
−0
—
—
—
EBIT
3 122
2 127
−12
−4
3
Net financials
−3
—
−10
−6
−0
Profit before tax
3 118
2 126
−22
−10
3
Tax
−656
−439
—
—
—
Net profit
2 462
1 687
−22
−10
3
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
6 250
2 906
514
71
71
Equity
2 520
1 807
78
68
70
Long-term debt
0
0
—
—
0
Short-term debt
3 731
1 099
437
3
0
Total debt
3 731
1 099
437
3
0
Financial ratios
5-year trend
EBITDA margin
294900.0%
This company
15.8%
Market median
+1866356% vs market
2020
2024
Equity ratio
99.6%
This company
38.2%
Market median
+161% vs market
2020
2024
Return on equity
4.0%
This company
18.4%
Market median
-78% vs market
2020
2024
Net profit margin
282400.0%
This company
8.1%
Market median
+3486320% vs market
2020
2024
Asset turnover
-0.00×
This company
1.12×
Market median
-100% vs market
2020
2024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Noviral International AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network